Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009870

Options or other derivatives

  • Chief Scientific Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-02-13 Grant or award · Stock Option (Right to Buy) +300,000 300,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…